232 related articles for article (PubMed ID: 26395117)
21. Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
Bernadach M; Lapeyre M; Dillies AF; Miroir J; Casile M; Moreau J; Molnar I; Ginzac A; Pham-Dang N; Saroul N; Durando X; Biau J
BMC Cancer; 2021 Apr; 21(1):360. PubMed ID: 33827483
[TBL] [Abstract][Full Text] [Related]
22. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
Céruse P; Cosmidis A; Belot A; Rabilloud M; Fuchsmann C; Poupart M; Ramade A; Tartas S; Favrel V; Pommier P; Zrounba P; Fayette J
Anticancer Drugs; 2014 Sep; 25(8):970-5. PubMed ID: 24849707
[TBL] [Abstract][Full Text] [Related]
23. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
Lefebvre JL; Pointreau Y; Rolland F; Alfonsi M; Baudoux A; Sire C; de Raucourt D; Malard O; Degardin M; Tuchais C; Blot E; Rives M; Reyt E; Tourani JM; Geoffrois L; Peyrade F; Guichard F; Chevalier D; Babin E; Lang P; Janot F; Calais G; Garaud P; Bardet E
J Clin Oncol; 2013 Mar; 31(7):853-9. PubMed ID: 23341517
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic strategies, oncologic and swallowing outcomes and their predictive factors in patients with locally advanced hypopharyngeal cancer.
Mattei P; Thamphya B; Chamorey E; Scheller B; Château Y; Dassonville O; Poissonnet G; Culié D; Koulmann PH; Hechema R; Sudaka A; Saada E; Benezery K; Demard F; Elaldi R; Bozec A
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3629-3637. PubMed ID: 35076745
[TBL] [Abstract][Full Text] [Related]
25. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
26. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
Pfister DG; Strong E; Harrison L; Haines IE; Pfister DA; Sessions R; Spiro R; Shah J; Gerold F; McLure T
J Clin Oncol; 1991 May; 9(5):850-9. PubMed ID: 2016629
[TBL] [Abstract][Full Text] [Related]
27. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and
Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R
Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526
[TBL] [Abstract][Full Text] [Related]
28. Long-term update of the 24954 EORTC phase III trial on larynx preservation.
Henriques De Figueiredo B; Fortpied C; Menis J; Lefebvre JL; Barzan L; de Raucourt D; Geoffrois L; Giurgea L; Hupperets P; Leemans CR; Licitra L; Rolland F; Tesselaar M; Vermorken JB; Grégoire V;
Eur J Cancer; 2016 Sep; 65():109-12. PubMed ID: 27494036
[TBL] [Abstract][Full Text] [Related]
29. Neo-adjuvant chemotherapy in advanced hypopharyngeal carcinoma.
Joshi P; Patil V; Joshi A; Norohna V; Chaturvedi P; Chaukar D; Pai P; Nair D; Juvekar S; Agarwal JP; D'Cruz AK; Prabhash K
Indian J Cancer; 2013; 50(1):25-30. PubMed ID: 23713041
[TBL] [Abstract][Full Text] [Related]
30. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
[TBL] [Abstract][Full Text] [Related]
31. Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.
Lim SH; Lee SJ; Ahn MJ; Park K; Sun JM
Jpn J Clin Oncol; 2016 Jan; 46(1):40-5. PubMed ID: 26561556
[TBL] [Abstract][Full Text] [Related]
32. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
[TBL] [Abstract][Full Text] [Related]
33. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M
Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685
[TBL] [Abstract][Full Text] [Related]
34. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
35. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
[TBL] [Abstract][Full Text] [Related]
36. Chemoselection combined with alternating chemoradiotherapy or surgery for hypopharyngeal cancer.
Matsuzuka T; Sato H; Suzuki R; Suzuki M; Saijoh S; Ikeda M; Nakaegawa Y; Tani A; Imaizumi M; Matsui T; Nomoto Y; Nomoto M; Tada Y; Suzuki Y; Omori K
Laryngoscope; 2016 Jun; 126(6):1349-53. PubMed ID: 26536058
[TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma.
Li R; Ye L; Zhu Y; Ding H; Wang S; Ying H; Wu C; Zhou L; Wang X; Tian S
Head Neck; 2022 Sep; 44(9):2018-2029. PubMed ID: 35915867
[TBL] [Abstract][Full Text] [Related]
38. EGR1 regulates radiation-induced apoptosis in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2015 Apr; 33(4):1717-22. PubMed ID: 25710185
[TBL] [Abstract][Full Text] [Related]
39. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
[TBL] [Abstract][Full Text] [Related]
40. Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes.
Mattei P; Gal J; Chamorey E; Dassonville O; Poissonnet G; Aloi D; Barret M; Safta I; Saada E; Sudaka A; Culié D; Bozec A
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]